Differential expression of <em>COL4A3</em> and collagen in upward and downward progressing types of nasopharyngeal carcinoma

Yang,Xiting; Wu,Qiuji; Wu,Fengyang; Zhong,Yahua

doi:10.3892/ol.2021.12484

March-2021 Volume 21 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2021 Volume 21 Issue 3

Full Size Image

Article Open Access

Differential expression of COL4A3 and collagen in upward and downward progressing types of nasopharyngeal carcinoma

Authors:
- Xiting Yang
- Qiuji Wu
- Fengyang Wu
- Yahua Zhong
View Affiliations / Copyright

Affiliations: Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China

Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 223
|
Published online on: January 21, 2021

https://doi.org/10.3892/ol.2021.12484
Expand metrics +

Abstract

Upward (local growth and invasion of the base of skull), downward (distant metastasis) and mixed progressing types of nasopharyngeal carcinoma (NPC) have been identified and are distinctly different with respect to clinical symptoms, therapeutic strategies and prognosis. The present study aimed to identify the genetic difference and collagen expression levels in the upward and downward progressing types of NPC. Whole exon sequencing (WES) was used to detect genes differentially mutated between the upward and downward progressing types of NPC. Collagen deposition in the upward and downward progressing types of NPC was determined using Masson trichromatic staining, while the protein expression level of COL4A3 was detected using immunohistochemistry. Survival analysis was also performed using the Kaplan-Meier Plotter database to examine the role of COL4A3 expression level in the prognosis of head and neck squamous cell carcinoma. Knockdown of COL4A3 was performed using short interfering (si)RNA-COL4A3 in a 5-8F NPC cell line. Reverse transcription-quantitative PCR and western blot analyses were utilized to analyze the mRNA and protein expression levels of COL4A3, respectively. The roles of COL4A3 in the migration and invasion of the 5-8F cell line were examined using wound-healing Transwell and Matrigel assays, respectively. A total of 21 genes were differentially mutated between the upward and downward progressing types of NPC. The COL4A3 was investigated further, as it was found to be associated with extracellular matrix deposition and cancer metastasis. The COL4A3 gene was markedly downregulated in the downward progressing type compared with that in the upward progressing type (2.161±1.306 vs. 5.077±3.619; P<0.05). In addition, the deposition of collagen in the downward progressing type was also significantly decreased compared with that in the upward progressing type (5.63±6.83 vs. 10.94±9.60; P<0.05). Kaplan-Meier analysis indicated that high expression level of COL4A3 was positively associated with a favorable prognosis of head and neck squamous cell carcinoma (HR, 0.69; 95% CI, 0.49‑ 0.97; P=0.031). To confirm the role of COL4A3, the expression level of COL4A3 was knocked down using siRNA in the 5-8F cell line and the results showed that the invasion and migration was significantly increased when the expression of COL4A3 was inhibited (P<0.0001). In conclusion, the gene mutation patterns were significantly different between the upward and downward progressing types of NPC. In addition, the expression level of the COL4A3 gene was decreased in the downward progressing type, which might promote NPC metastasis through the downregulation of extracellular collagen expression.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
2	Carioli G, Negri E, Kawakita D, Garavello W, La Vecchia C and Malvezzi M: Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas. Int J Cancer. 140:2256–2264. 2017. View Article : Google Scholar : PubMed/NCBI
3	Sun P, Chen C, Chen XL, Cheng YK, Zeng L, Zeng ZJ, Liu LZ, Su Y and Gu MF: Proposal of a clinical typing system and generation of a prognostic model in patients with nasopharyngeal carcinoma from Southern China. J BUON. 19:474–483. 2014.PubMed/NCBI
4	Liang WJ, Qiu F, Hong MH, Guo L, Qin HD, Liu QC, Zhang XS, Mai HQ, Xiang YQ, Min HQ, et al: Differentially expressed genes between upward and downward progressing types of nasopharyngeal carcinoma. Chin J Cancer. 27:460–465. 2008.(In Chinese).
5	Mo L, Weng J, Zeng F, Li X, Liu B, Li Z and Kuang G: The relationship between extend types and distant metastasis of nasopharyngeal carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 24:554–555, 558. 2010.(In Chinese). PubMed/NCBI
6	Chew MM, Gan SY, Khoo AS and Tan EL: Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer. 10:5742010. View Article : Google Scholar : PubMed/NCBI
7	Morrissey MA, Jayadev R, Miley GR, Blebea CA, Chi Q, Ihara S and Sherwood DR: SPARC promotes cell invasion in vivo by decreasing type IV collagen levels in the basement membrane. PLoS Genet. 12:e10059052016. View Article : Google Scholar : PubMed/NCBI
8	Tanjore H and Kalluri R: The role of type IV collagen and basement membranes in cancer progression and metastasis. Am J Pathol. 168:715–717. 2006. View Article : Google Scholar : PubMed/NCBI
9	Timpl R, Wiedemann H, van Delden V, Furthmayr H and Kühn K: A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem. 120:203–211. 1981. View Article : Google Scholar : PubMed/NCBI
10	Mundel TM and Kalluri R: Type IV collagen-derived angiogenesis inhibitors. Microvasc Res. 74:85–89. 2007. View Article : Google Scholar : PubMed/NCBI
11	Khoshnoodi J, Pedchenko V and Hudson BG: Mammalian collagen IV. Microsc Res Tech. 71:357–370. 2008. View Article : Google Scholar : PubMed/NCBI
12	Ikeda K, Iyama K, Ishikawa N, Egami H, Nakao M, Sado Y, Ninomiya Y and Baba H: Loss of expression of type IV collagen alpha5 and alpha6 chains in colorectal cancer associated with the hypermethylation of their promoter region. Am J Pathol. 168:856–865. 2006. View Article : Google Scholar : PubMed/NCBI
13	Tanaka K, Iyama K, Kitaoka M, Ninomiya Y, Oohashi T, Sado Y and Ono T: Differential expression of alpha 1(IV), alpha 2(IV), alpha 5(IV) and alpha 6(IV) collagen chains in the basement membrane of basal cell carcinoma. Histochem J. 29:563–570. 1997. View Article : Google Scholar : PubMed/NCBI
14	Dehan P, Waltregny D, Beschin A, Noel A, Castronovo V, Tryggvason K, De Leval J and Foidart JM: Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. Am J Pathol. 151:1097–1104. 1997.PubMed/NCBI
15	Pan XX, Tong LH, Chen YF, Li FL, Tang WB, Liu YJ and Yang WA: simplified T classification based on the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma. Cancer Manag Res. 11:3163–3169. 2019. View Article : Google Scholar : PubMed/NCBI
16	Zhang G, Fedyunin I, Kirchner S, Xiao C, Valleriani A and Ignatova Z: FANSe: An accurate algorithm for quantitative mapping of large scale sequencing reads. Nucleic Acids Res. 40:e832012. View Article : Google Scholar : PubMed/NCBI
17	Huang W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
18	Yu G, Wang LG, Han Y and He QY: clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
19	Nagy Á, Lánczky A, Menyhárt O and Győrffy B: Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 8:92272018. View Article : Google Scholar : PubMed/NCBI
20	Wei X, Li S, He J, Du H, Liu Y, Yu W, Hu H, Han L, Wang C, Li H, et al: Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling. Cell Commun Signal. 17:582019. View Article : Google Scholar : PubMed/NCBI
21	Guo S and Deng CX: Effect ofstromal cells in tumor microenvironment on metastasis initiation. Int J Biol Sci. 14:2083–2093. 2018. View Article : Google Scholar : PubMed/NCBI
22	Kaur A, Ecker BL, Douglass SM, Kugel CH III, Webster MR, Almeida FV, Somasundaram R, Hayden J, Ban E, Ahmadzadeh H, et al: Remodeling of the collagen matrix in aging skin promotes melanoma metastasis and affects immune cell motility. Cancer Discov. 9:64–81. 2019. View Article : Google Scholar : PubMed/NCBI
23	Chelberg MK, Tsilibary EC, Hauser AR and McCarthy JB: Type IV collagen-mediated melanoma cell adhesion and migration: Involvement of multiple, distinct domains of the collagen molecule. Cancer Res. 49:4796–4802. 1989.PubMed/NCBI
24	Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A and Kalluri R: Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell. 3:589–601. 2003. View Article : Google Scholar : PubMed/NCBI
25	Hamano Y and Kalluri R: Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun. 333:292–298. 2005. View Article : Google Scholar : PubMed/NCBI
26	Maeshima Y, Colorado PC and Kalluri R: Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem. 275:23745–23750. 2000. View Article : Google Scholar : PubMed/NCBI
27	Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y and Zhang ZY: Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Chin Med J (Engl). 121:2324–2330. 2008. View Article : Google Scholar : PubMed/NCBI
28	Maeshima Y, Yerramalla UL, Dhanabal M, Holthaus KA, Barbashov S, Kharbanda S, Reimer C, Manfredi M, Dickerson WM and Kalluri R: Extracellular matrix-derived peptide binds to alpha_vbeta₃ integrin and inhibits angiogenesis. J Biol Chem. 276:31959–31968. 2001. View Article : Google Scholar : PubMed/NCBI
29	Maeshima Y, Sudhakar A, Lively JC, Ueki K, Kharbanda S, Kahn CR, Sonenberg N, Hynes RO and Kalluri R: Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science. 295:140–143. 2002. View Article : Google Scholar : PubMed/NCBI
30	Pasco S, Ramont L, Venteo L, Pluot M, Maquart FX and Monboisse JC: In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res. 301:251–265. 2004. View Article : Google Scholar : PubMed/NCBI
31	Hou P, Chen Y, Ding J, Li G and Zhang H: A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy. Am J Nephrol. 27:538–544. 2007. View Article : Google Scholar : PubMed/NCBI
32	Rana K, Tonna S, Wang YY, Sin L, Lin T, Shaw E, Mookerjee I and Savige J: Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. Pediatr Nephrol. 22:652–657. 2007. View Article : Google Scholar : PubMed/NCBI
33	Saravani R, Yari D, Saravani S and Hasanian-Langroudi F: Correlation between the COL4A3, MMP-9, and TIMP-1 polymorphisms and risk of keratoconus. Jpn J Ophthalmol. 61:218–222. 2017. View Article : Google Scholar : PubMed/NCBI
34	Saravani S, Yari D, Saravani R and Azadi Ahmadabadi C: Association of COL4A3 (rs55703767), MMP-9 (rs17576)and TIMP-1 (rs6609533) gene polymorphisms with susceptibility to type 2 diabetes. Biomed Rep. 6:329–334. 2017. View Article : Google Scholar : PubMed/NCBI
35	Hao XD, Chen XN, Zhang YY, Chen P, Wei C, Shi WY and Gao H: Multi-level consistent changes of the ECM pathway identified in a typical keratoconus twins family by multi-omics analysis. Orphanet J Rare Dis. 15:2272020. View Article : Google Scholar : PubMed/NCBI
36	Jiang CP, Wu BH, Chen SP, Fu MY, Yang M, Liu F and Wang BQ: High COL4A3 expression correlates with poor prognosis after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer. Tumour Biol. 34:415–420. 2013. View Article : Google Scholar : PubMed/NCBI
37	Nie XC, Wang JP, Zhu W, Xu XY, Xing YN, Yu M, Liu YP, Takano Y and Zheng HC: COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas. Hum Pathol. 44:77–86. 2013. View Article : Google Scholar : PubMed/NCBI